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Abstract
The anterior and intermediate lobes of the pituitary are composed of endocrine cells, vasculature 
and supporting cells, such as folliculostellate cells. Folliculostellate cells form a network with 
several postulated roles in the pituitary, including production of paracrine signalling molecules 
and cytokines, coordination of endocrine cell hormone release, phagocytosis and structural 
support. Folliculostellate cells in rats are characterised by expression of S100B protein, and in 
humans by GFAP. However, there is evidence for another network of supporting cells in the 
anterior pituitary that has  properties of mural cells such as vascular smooth muscle cells and 
pericytes. 
This study aims to characterise the distribution of cells that express the mural cell marker 
PDGFRβ in the mouse pituitary and establish whether these cells are folliculostellate. By 
immunohistochemical localisation we determine that approximately 80% of PDGFRβ+ cells in the 
mouse pituitary have a non-perivascular location, and 20% are pericytes. Investigation of gene 
expression in a magnetic cell sorted population of PDGFRβ+ cells shows that, despite a mostly 
non-perivascular location, this population is enriched for mural cell markers, but not enriched for 
rat or human folliculostellate cell markers. This is confirmed by immunohistochemistry.
This study concludes that a mural cell network is present throughout the anterior pituitary of the 
mouse, and that this population does not express well-characterised human or rat 
folliculostellate cell markers. 
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This article is protected by copyright. All rights reserved
Introduction
The pituitary is an endocrine gland located underneath the brain that produces and releases 
circulating hormones in response to signals from the hypothalamus. It is formed of three lobes. 
Neurons in the posterior lobe (pars nervosa) connect to the hypothalamus and store oxytocin 
and vasopressin. The intermediate lobe (pars intermedia) is formed of melanotrophs that 
produce melanocyte stimulating hormone (MSH), and the anterior lobe (pars distalis) is formed 
of heterogeneous specialised endocrine cells that each make a particular hormone type: 
adrenocorticotrophic hormone (ACTH) is made by corticotrophs, growth hormone (GH) by 
somatotrophs, prolactin by lactotrophs, thyroid stimulating hormone (TSH) by thyrotrophs and 
the gonadotrophins follicle stimulating hormone (FSH) and luteinising hormone (LH) by 
gonadotrophs. The folliculostellate cell is a further, non-endocrine cell type in the anterior 
pituitary. Folliculostellate cells are named after their appearance in electron micrographs: they 
have a distinctive stellate shape and surround follicular structures 1. Their long cytoplasmic 
processes connect to form a three-dimensional network 2 that is thought to perform multiple 
roles in the pituitary including production of paracrine signalling molecules and cytokines 1, 
coordination of endocrine cell hormone release 3, phagocytosis 4 and structural support 5. There 
is evidence that folliculostellate cells in rats are composed of multiple subpopulations that may 
arise from different precursors 6. 
Mural cells such as vascular smooth muscle cells and pericytes are required for the formation and 
stability of the vasculature and the support of endothelial cells. They are characterised by the 
expression of the markers Chondroitin Sulfate Proteoglycan 4 (CSPG4, more commonly known as 
nerve/glial antigen 2 or NG2), alpha smooth muscle actin (SMA) and platelet derived growth 
factor receptor beta (PDGFRβ) 7, 8. In rat anterior pituitaries they have also been shown to 
express desmin 9. A recently published paper has shown that mouse folliculostellate cells express 
NG2, and that inactivation of retinoblastoma protein in NG2+ cells resulted in adenohypophysial 
tumours with immunohistochemical and ultrastructural features that resemble those of 
aggressive Pit1-lineage tumours in humans 10.  Furthermore, PDGFRβ has been shown to be 
expressed in the mouse TtT/GF folliculostellate cell line 11. Together, this evidence suggests that 
either mouse pituitary folliculostellate cells may have mural cell-like properties, or mural cells 









This article is protected by copyright. All rights reserved
characterise the distribution of PDGFRβ+ cells in the mouse pituitary and establish whether these 
cells have folliculostellate cells and/or mural-like properties. 
Methods 
Breeding and maintenance of mice
Mice were fed a soya-free diet. Experimental procedures and animal breeding and maintenance 
were approved by University of Edinburgh Animal Welfare and Ethical Review Body and were 
carried out with licenced permission under project licence 70/8804 held by Professor Lee B. 
Smith in line with the UK Home Office Animals (Scientific Procedures) Act, 1986. 
Immunohistochemistry
NG2 staining was only possible with cryopreserved sections. To co-stain for NG2 and PDGFRβ, 
Pituitaries were frozen on dry ice and transferred to a -80°C freezer. Prior to sectioning, 
pituitaries were encompassed in Tissue-Tek OCT compound (Sakura), mounted on a cryostat 
chuck, sectioned at 5 µm and mounted on poly lysine coated slides (Sigma-Aldrich PO425-72EA). 
Sections were dried at room temperature for 12 hours, then sections fixed under a droplet of 4% 
buffered formaldehyde for 5 minutes. Slides were then stained with a double fluorescent 
tyramide method as described previously 15, 16 using antibodies to NG2 (Millipore Cat# AB5320, 
RRID:AB_91789, 1 in 8000 dilution) and PDGFRβ (Abcam Cat# ab32570, RRID:AB_777165, 1 in 
8000 dilution). A non-pressurised heating by microwave in pH6 0.01M sodium citrate buffer was 
performed after the first tyramide reaction to denature remaining antibodies from the first set 
and avoid non-specific reactions with the second set of antibodies17. Double staining of either 
NG2 first or PDGFRβ first, both with and without primary antibodies, was performed to verify this 
(Supplementary Data 4). 
All other antibodies could be used on formaldehyde-fixed paraffin-embedded sections. 
Pituitaries were fixed for 24 hours in 4% buffered formaldehyde. Fixed tissues were processed 
and embedded in paraffin wax, and 3µm sections were used for immunohistochemical analysis. 
Fluorescent immunostaining was performed either by single or double antibody tyramide 
fluorescent immunostaining method, as described previously 15, 16. Antibodies used were PDGFRβ 
(Abcam Cat# ab32570, RRID:AB_777165, 1 in 1000), S100 (Agilent Cat# Z0311, lot number 
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in 500) optimised for the method and conditions used. A non-pressurised heating by microwave 
in pH6 0.01M sodium citrate buffer was performed after the first tyramide reaction to denature 
remaining antibodies from the first set and avoid non-specific reactions with the second set of 
antibodies 17.
On resin-perfused sections, staining was performed using a colourimetric method. Briefly, 
sections were deparaffinised and rehydrated, and high-pressure antigen retrieval was performed 
in citrate buffer. Slides were incubated with NGS/TBS/BSA to block non-specific antibody binding, 
before being incubated overnight with rabbit anti- PDGFRβ (Abcam Cat# ab32570, 
RRID:AB_777165, 1 in 400) in NGS/TBS/BSA. The next day, slides were incubated with 
biotinylated goat anti-rabbit (Vector Laboratories Cat# BA-1000, RRID:AB_2313606, 1 in 500), 
then streptavidin-conjugated alkaline phosphatase (Vector Laboratories Cat# SA-5100, 
RRID:AB_2336093, 1 in 200), then PermaBlue Plus/AP (Diagnostic BioSystems K058, diluted to 
manufacturer’s instructions) to form a blue precipitate localised to PDGFRβ protein. Slides were 
then mounted using an aqueous mounting medium and visualised with a Provis light microscope 
and camera. 
Magnetic activated cell sorting (MACS)
Pituitaries were removed during dissection and the anterior lobes were dissected and used for 
MACS. Anterior pituitaries from approximately 40 mice on a mixed C57Bl/6 background were 
used in each MACS experiment, and MACS was repeated three times. The pool of anterior 
pituitaries was digested into a single cell suspension following a previously published protocol 18. 
MACS was performed using protocols and reagents from Miltenyi Biotec (Bergisch Gladbach, 
Germany). Briefly: the single cell suspension was incubated first with 1:500 PDGFRβ antibody 
(Abcam Cat# ab32570, RRID:AB_777165), then with anti-rabbit IgG magnetic microbeads 
(Miltenyi 130-048-602) before passing through a Miltenyi MS column (Miltenyi 130-042-201) in a 
magnetic holder. Both the column-bound cell fraction (MACS+) and the flow-through cell fraction 
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Recovered whole pituitaries, dissected pituitaries and MACS cell pellets were frozen on dry ice 
before being transferred to a -80oC freezer for storage. RNA was isolated using the RNeasy Mini 
extraction kit (Qiagen, Crawley, UK) according to the manufacturer’s instructions. RNA was 
quantified and assessed using a NanoDrop 1000 spectrophotometer (Thermo Fisher Scientific, 
Waltham, MA, USA). All RNA samples had a A260/A280 ratio of above 1.9, and a A260/A230 ratio 
of above 1.5. Random hexamer primed cDNA was prepared using the SuperScript VILO cDNA 
synthesis kit (Life Technologies) according to manufacturer’s instructions.
Quantitative RT-PCR (qPCR)
Multiplex qPCR was performed on cDNA for the genes listed in Table 1 using an ABI Prism 7900 
Sequence Detection System (Applied Biosystems) and the Roche Universal Probe library (Roche, 
Welwyn, UK). The expression of all genes was related to an internal housekeeping gene assay for 
Actb (Roche, Welwyn, UK) as described previously 16. Actb Ct values were similar between 
samples when normalised to the number of cells that had been RNA extracted. Resulting data 
were analysed using the ΔΔCt method. 
Resin perfusion 
Resin perfused pituitaries were obtained from Dr Diane Rebourcet (University of Newcastle, 
Australia), prepared following previously published protocols 19. 
Immunogold Electron microscopy
Pituitaries were fixed in 2.5% glutaraldehyde and 2% paraformaldehyde in 0.1M phosphate 
buffer, pH 7.2 at room temperature for 3 hours, then transferred to 0.25% glutaraldehyde and 
0.2% paraformaldehyde in 0.1M phosphate buffer, pH 7.2 and then kept at 4°C. Pituitaries were 
prepared for immunogold electron microscopy as previously described 20. Briefly, cells were post-
fixed in osmium tetroxide (1% wt/vol in 0.1 M sodium phosphate buffer), contrasted with uranyl 
acetate (2% wt/vol in distilled water), dehydrated through increasing concentrations of ethanol 
(70–100%) and embedded in Spurr's resin. Ultra-thin sections (50–80 nm) cut and stained with 
antibody to PDGFRβ (Abcam Cat# ab32570, RRID:AB_777165). Sections were viewed with a 
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Results
PDGFRβ cells were found in the anterior, intermediate and posterior lobes of the mouse 
pituitary
Stellate PDGFRβ cells were widely distributed in the anterior and posterior lobes of the adult 
pituitary, with fewer seen in the intermediate lobe (Figure 1A). PDGFRβ cells were also present in 
the day (d)1 neonatal anterior pituitary as stellate shaped cells and cell clusters and in a layer of 
spindle-shaped cells around the outside of the anterior pituitary (Figure 1B). Mural pericytes 
have a characteristic location and morphology, defined as being adjacent to endothelial cells and 
wrapping around the vasculature 21. In the rat anterior pituitary, desmin-positive perivascular 
cells can be found detached from capillaries, although with cytoplasmic processes still in contact 
with the capillary wall 22.  To visualise whether PDGFRβ+ cells are found only in a perivascular 
location in the anterior pituitary, we immunostained for PDGFRβ in sections of pituitary from 
adult mice that had been intravascularly perfused with an opaque resin at termination 19. Both 
large and small blood vessels can be visualised by this technique. The percentage of PDGFRβ+ 
cells in contact with and not in contact with blood vessels was then quantified. Although 20% of 
PDGFRβ+ cells were seen to be either contacting or surrounding anterior pituitary blood vessels 
in a location characteristic of pericytes, 80% were located in the pituitary parenchyma in a 
location and distribution characteristic of folliculostellate cells (Figure 1C). To identify PDGFRβ 
cells by ultrastructure, immunogold electron microscopy was performed with a PDGFRβ 
antibody. Folliculostellate cells and pericytes were identified by location and ultrastructure 
(Supplementary data 3).  Both folliculostellate cells (Figure 2A) and pericytes (Figure 2B) were 
found to localise PDGFRβ. 
PDGFRβ cells of the anterior pituitary were found to express other mural cell markers
To investigate whether pituitary PDGFRβ+ cells express other mural cell markers, a population of 
cells enriched for PDGFRβ was generated by MACS from micro-dissected anterior pituitaries 
using the same PDGFRβ antibody used for immunohistochemistry (Figure 3A). These markers 
were examined by qPCR in whole pituitaries and dissected anterior pituitaries, as well as PDGFRβ 
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Cspg4 (NG2 transcript) was enriched in a PDGFRβ MACS+ population at 10-fold higher than the 
MACS- population, 7-fold higher than the whole anterior pituitary and 7-fold higher than the 
whole intact pituitary (Figure 3B). This was confirmed by immunohistochemistry for NG2 protein 
in cryosections of whole mouse pituitary. Staining of NG2 colocalised with PDGFRβ in the 
anterior lobe in a stellate shaped cell pattern (Figure 3C). Other mural cell markers were enriched 
in the PDGFRβ cell population of the mouse pituitary. Acta2 (SMA transcript) was enriched in the 
MACS+ population at 5-fold higher than the MACS- population, 9-fold higher than the whole 
anterior pituitary and 2-fold higher than the whole intact pituitary PDGFRα transcript (Figure 3D). 
Desmin transcript Des was enriched in the MACS+ population at 11-fold higher than the MACS- 
population, 3-fold higher than the whole anterior pituitary and 3.5-fold higher than the whole 
intact pituitary (Figure 3E). Since PDGFRβ is also considered a marker of mesenchymal stem cells 
(MSCs)23, PDGFRβ enriched cell population was also tested for Pdgfra, a MSC marker. Pdgfra 24 
was enriched in the MACS PDGFRβ + population at 12.5-fold higher than the MACS- population, 
2.5-fold higher than the whole anterior pituitary and 1.4-fold higher than the whole intact 
pituitary (Figure 3F). These results indicate that the PDGFRβ+ cell population in the anterior 
pituitary is enriched for mural cell and perivascular MSC markers. 
PDGFRβ cells of the mouse anterior pituitary did not express rat or human folliculostellate cell 
markers
We then investigated whether pituitary PDGFRβ cells express the same markers as rat and 
human folliculostellate cells. These markers were examined by qPCR in whole pituitaries and 
dissected anterior pituitaries, as well as positive and negative purified MACS populations. 
Sections of whole pituitary were also stained for the markers where an appropriate antibody was 
available. 
Localisation of S100 calcium-binding protein B (S100B) is a characteristic of folliculostellate cells 
in rats 25. S100b transcript was not enriched in the MACS+ population compared to the MACS- 
population and was present at 1.6-fold lower than the whole anterior pituitary and 4-fold lower 
than the level of the whole intact pituitary.  (Figure 4A). Since it was found to be enriched in 
whole pituitaries compared to dissected anterior pituitaries, it is likely that it is enriched in 
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protein in whole mouse pituitary sections. S100 staining was not seen in the parenchyma of the 
anterior lobe (Figure 4B) but was seen in a population of cells lining the cleft on both the AP and 
IP sides (Figure 4C). As positive controls to ensure that the antibody is functional, staining could 
be seen both in astrocyte and tanycyte cells in the mouse hypothalamus (Figure 4D) and in 
sections of rat pituitary (Figure 4E), as expected. Glial fibrillary acid protein (GFAP) is a 
folliculostellate cell marker in humans 26. Gfap was not enriched in the MACS+ population 
compared to the MACS- population or compared to whole anterior pituitary but was present in 
whole pituitaries at 14.5-fold the level of the MACS+ cell population (Figure 4F). Since it was 
highly enriched in whole pituitaries compared to dissected anterior pituitary samples, it is likely 
that it is enriched in intermediate or posterior lobe cells. This was confirmed by 
immunohistochemistry for GFAP protein in whole mouse pituitary sections. Staining was not 
seen in the parenchyma of the anterior lobe (Figure 4G). As a positive control to ensure that the 
antibody is functional, staining could be seen in astrocytes in the mouse brain (Figure 4H). These 
results indicate that the PDGFRβ+ cell population in the anterior pituitary is not enriched for rat 
or human folliculostellate cell markers. 
SOX2+ cells in the adult pituitary gland did not express PDGFRβ
To clarify whether PDGFRβ+ cells in the pituitary express the previously characterised pituitary 
stem cell marker SOX2 we performed double immunohistochemistry for these proteins. 
PDGFRβ+ cells did not co-stain with SOX2 in adult pituitaries (Figure 5A) or in neonatal pituitaries 
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Discussion
 
A network of mural cells in the mouse pituitary has a spatial distribution similar to 
folliculostellate cells
In this study we have shown that staining for PDGFRβ is present throughout the mouse pituitary 
in a network of cells with a stellate shape. PDGFRβ is a marker of mural cells such as pericytes 
and vascular smooth muscle cells, and also of mesenchymal stem cells (MSCs) 23 and fibroblasts 
27 of some tissues. Although 20% of the cells seen to stain for PDGFRβ in the anterior pituitary 
interact with blood vessels, 80% did not make contact. The expression pattern of PDGFRβ in the 
pituitary parenchyma was similar to previous staining of folliculostellate cells in the mouse 
pituitary using an antibody to ER-BMDM1 28.. Since other cells such as MSCs and fibroblasts 
express PDGFRβ, we aimed to characterise whether mouse anterior pituitary parenchymal 
PDGFRβ+ cells expressed any other mural cell markers. In this study we have shown that anterior 
pituitary PDGFRβ+ cells co-stain with NG2 which is also a marker of mural cells, but not MSCs 23 
or fibroblasts 29. This expression pattern is consistent with a previous publication which has also 
localised NG2 to a network of cells with a stellate shape, although that paper designated the cells 
as mouse pituitary folliculostellate cells 10.  A few cells appear to stain for NG2 or PDGFRβ only. 
This could be an artefact of the staining, or it could be that there are some cells in the anterior 
pituitary that are NG2+/PDGFRβ- and NG2-/ PDGFRβ+. Without further investigation it is difficult 
to conclude which possibility is true. Our evidence suggests that a population of mural cells in the 
mouse anterior pituitary has a network structure very similar to that of folliculostellate cells, and 
that this network extends away from the vasculature.
The novel mural cell network does not express folliculostellate cell markers 
The folliculostellate cells of the pituitary also form a network, which is commonly characterised 
by expression of S100B or GFAP markers in immunohistochemistry. 473 papers published 
between 1972 and November 2019 that mention the words “folliculostellate” or “folliculo-
stellate” in their abstract have been indexed on Pubmed. Of these, 426 are primary research 
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model to investigate pituitary folliculostellate cells, either in whole pituitaries, primary cell 
culture or derived cell lines. Folliculostellate cells in rats are defined by their expression of the 
calcium binding protein S100B but are considered functionally heterogeneous, arising from three 
different developmental origins 6. Astrocyte-like folliculostellate cells express glial fibrillary acidic 
protein (GFAP) as a marker, dendritic cell-like folliculostellate cells are thought to arise from 
MAC-1+ early macrophages and express MH-class II as a marker, and epithelial-like 
folliculostellate cells express neither of these. The use of S100B as a marker and the availability 
of a S100-GFP reporter rats 25 has resulted in the rat becoming the most widely used model 
organism for folliculostellate cell research, and most folliculostellate cell characterisation is based 
on their phenotype in rats. Pericytes and folliculostellate cells are distinct populations in rats 30, 
but there is also evidence in rats that pericyte-like cells may be found in contact with (but not 
enveloping) capillaries 22.
Mouse folliculostellate cells are not well-investigated compared to rats and only 25 of these 423 
primary research papers use mice as a model. To determine whether the network of PDGFRβ 
cells we characterised in the mouse anterior pituitary  expressed the rat folliculostellate cell 
marker S100B or the human folliculostellate cell marker GFAP, we attempted to detect these 
proteins by immunohistochemistry on whole anterior pituitaries and transcripts by qPCR on a 
MACS purified population of PDGFRβ cells. Our results showed that GFAP is not expressed in the 
anterior pituitary, and S100 is only expressed in cells of the anterior pituitary lining the pituitary 
cleft, and not in the body of the anterior pituitary. Neither GFAP or S100 are enriched in mouse 
anterior pituitary PDGFRβ cells. However, utilising immunogold electron microscopy for PDGFRβ 
shows it localised to cells with ultrastructural characteristics of both folliculostellate cells and 
pericytes. Previous studies (including those that have used the same antibody as we used in this 
study) have shown S100 staining in the pituitary 31-37, although these S100-positive cleft cells are 
often defined as ‘folliculostellate cells’ but do not show staining throughout the parenchyma. 
Interestingly, Allaerts et al. 38 note that they do not see S100 staining in the mouse pituitary. The 
S100+ cells found in the cleft are also likely to be SOX2+ due to their location and previous 
reports of co-staining of SOX2 and S100 in the rat 39. 
A further 54 papers have been published using the TtT/GF cell line, which is an immortal cell line 
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on strong immuno-positive staining for GFAP and weak staining for S100 protein 40. The TtT/GF 
cell line was isolated from a mouse thyrotrophic tumour that had been induced by 
radiothyroidectomy so it is possible that the transformation of these cells and their culture ex 
vivo has changed the characteristics of the cell line from that of the originating cell in vivo. 
However, it is also interesting to note that a recent paper discusses that the TtT/GF cell line has 
‘pericyte characteristics’ including the expression of NG2 41. It is likely that this is a 
folliculostellate cell line but has either switched on or increased expression of S100 as well as 
mural cell markers, or that it has been derived from a sub-population of folliculostellate cells 6, 
potentially the from the SOX2+ S100+ population of cleft cells. Our evidence suggests that the 
mural cell network in the mouse anterior pituitary are not folliculostellate cells, although we 
could not establish a folliculostellate marker to use to unambigulously determine this, so there is 
still the possibility that these two networks overlap. 
SOX2+ cells of the anterior pituitary are not PDGFRβ+
The source of dividing cells in the anterior pituitary is thought to change throughout 
development. Previous studies show that the very earliest progenitor cells in the developing 
pituitary come from SOX2+ cells lining Rathke’s pouch, which at e12.5 ubiquitously express the 
transcription factor SOX2 and are highly proliferative 43. From e12.5 to e17.5, between 20-30% of 
SOX2+ cells are dividing at any given point 44. By E14.5, SOX2 is confined to the intermediate lobe 
and periluminal cells in the anterior lobe and by e16.5, dividing cells begin to switch off SOX2 and 
switch on the lineage-specific transcription factors TPIT (a.k.a. TBX19: corticotrophs and 
melanotrophs), SF1 (gonadotrophs) and PIT1 (a.k.a. POU1F1: thyrotrophs, somatotrophs and 
lactotrophs) 33. Lineage tracing studies that use a tamoxifen-inducible Sox2-Cre to permanently 
express fluorescent marker proteins in these cells and their progeny have shown that all types of 
pituitary anterior lobe endocrine cells can develop from early SOX2+ cells, but not all cells are 
marked by the lineage tracer 31, 32, 43. A small number of SOX2+ cells persist in the postnatal 
pituitary, found lining the anterior-pituitary slide of the cleft and in small groups through the 
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which can differentiate into all types of pituitary endocrine cells, which has led to the suggestion 
that they might be pituitary stem cells  33. 
In the first three weeks of postnatal life, the pituitary undergrows rapid growth in which 
differentiated or differentiating endocrine cells increase their contribution to cell division, and 
SOX2+ cells decrease their contribution 45. SOX2+ cells contribute around 64% of dividing cells at 
d1, reduced to 19% at d10 and are mostly quiescent at d20. In contrast, the percentage of 
dividing cells that are Pit1-positive (a marker of differentiating lactotrophs, somatotrophs and 
thyrotrophs) increases from 16% to 87% over this time period 43. Two lineage tracing studies for 
SOX2+ cells have investigated the early postnatal period and concluded that only a small 
percentage of SOX2+ cells present in the neonatal pituitary develop into pituitary endocrine cells 
32, 43 and that most of the SOX2+ dividing cells develop into gonadotrophs. 
In adulthood it is thought that the adult pituitary gland is maintained by stochastic cellular self-
replication rather than stem cell replenishment, although stressing the pituitary by ablating a cell 
population or removing a feedback gland can prompt the mobilisation of SOX2+ stem cells. 
Lineage tracing experiments show that when SOX2-Cre is induced in adulthood, labelled cells 
rarely differentiate into different pituitary lineages and mostly remain as SOX2+ stem cells 31, 32, 
43. Taken together this evidence shows that SOX2+ stem cells have a large commitment to 
differentiating cells in embryonic period but a diminishing contribution after birth and little 
during adulthood. Our study shows that the SOX2+ cells lining the anterior epithelium of the 
pituitary cleft do not express PDGFRβ in adult or neonatal pituitaries. 
 
Conclusion
The anterior pituitary is composed of well-characterised networks of endocrine and 
folliculostellate cells 52. Here we present evidence that there is a population of mural cells in the 
anterior pituitary of the mouse that extends away from the vasculature to form a further 
network. The role of this mural cell network requires further characterisation: since pituitary 
vasculature is important for the coordination of hormone release 53, it is possible that it is 
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Tables
Table 1. Primers and Roche UPL probes for qRT-PCR assays used in these studies
Gene Forward primer Reverse primer Probe
Cspg4 cttggccttgttggtcagat cacctccaggtggttctcc 16
Des gccacctaccggaagctact gcagagaaggtctggataggaa 15
Acta2 gacaccacccacccagagt acatagctggagcagcgtct 20
Pdgfra ggtcctcagctgtctcctca cgtttgggaggatagagggta 51
Pdgfrb gctgatgaaggtctcccaga ggagctccaggggactgt 69
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Figure legends
Figure 1: PDGFRβ cells are found in the anterior and posterior lobes of the pituitary
(A) Fluorescent immunohistochemical staining of PDGFRβ (magenta) in formaldehyde-fixed 
paraffin-embedded thin sections of wild-type mouse pituitary with green counterstain, showing 
anterior (left), intermediate and posterior lobes. (B) Anterior lobe of postnatal day (pnd) 1 mouse 
pituitary showing both clusters of stellate-shaped cells and cells around the periphery of the lobe 
staining for PDGFRβ. All scale bars 50 µm. (C) Perma-blue staining of PDGFRβ (blue) in thin 
sections of pituitary from mice intravascularly perfused with an opaque resin at termination, 
marking larger vessels in brown (arrow) and smaller vessels in iridescent green (arrowhead), 
showing that PDGFRβ-positive cells are present both adjacent to pituitary blood vessels and in 
the parenchyma, scale bar 50 µm.
Figure 2: PDGFRβ is localised to cells with folliculostellate and pericyte morphology
Immunogold electron microscopy was performed with a PDGFRβ antibody. (A) Localisation in 
folliculostellate cells identified from location and ultrastructure. (B) Localisation in pericytes 
identified from location and ultrastructure. Scale bars 200 nm.
Figure 3: PDGFRβ cells of the anterior pituitary are enriched for mural cell markers
(A) Pdgfrb is enriched in the MACS PDGFRβ+ population at 12.1-fold higher than the MACS- 
population, 2.5-fold higher than the whole anterior pituitary and 3.9-fold higher than the whole 
intact pituitary. (B) Cspg4 (NG2 transcript) is enriched in a PDGFRβ MACS+ population at 10-fold 
higher than the MACS- population, 7-fold higher than the whole anterior pituitary and 7-fold 
higher than the whole intact pituitary. (C) Fluorescent immunochemistry for NG2 protein 
(magenta) in cryosections of whole wild-type mouse pituitary colocalises with PDGFRβ (green) in 
the anterior lobe in a stellate shaped cell pattern. Blue counterstain, scale bar 50 µm. (D) Acta2 
(SMA transcript) is enriched in the MACS+ population at 5-fold higher than the MACS- 
population,  9-fold higher than the whole anterior pituitary and 2-fold higher than the whole 
intact pituitary. (E) Des is enriched in the MACS+ population at 11-fold higher than the MACS- 
population,  3-fold higher than the whole anterior pituitary and 3.5-fold higher than the whole 
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the MACS- population, 2.5-fold higher than the whole anterior pituitary and 1.4-fold higher than 
the whole intact pituitary.
Figure 4: PDGFRβ cells of the mouse anterior pituitary are not enriched for rat folliculostellate 
cell markers
(A) S100b is not enriched in the MACS+ population compared to the MACS- population and is 
present at 1.6-fold lower than the whole anterior pituitary and 4-fold lower than the level of the 
whole intact pituitary. (B-E) Fluorescent immunohistochemical staining of pan-S100 (magenta) in 
formaldehyde-fixed paraffin-embedded thin sections of wild-type mouse pituitary and brain with 
green counterstain, scale bars 50 µm: (B) Staining is not seen in the parenchyma of the anterior 
lobe of the pituitary. (C) Staining is seen in a population of cells lining the cleft on both anterior 
and intermediate sides. (D) As positive controls to ensure that the antibody is functional, S100 
staining can be seen both in astrocyte and tanycyte cells in the mouse hypothalamus. (E) S100 
staining is seen in folliculostellate cells in sections of rat pituitary. (F) Gfap is not enriched in the 
MACS+ population compared to the MACS- population,  or compared to whole anterior pituitary, 
but is present in whole pituitaries at 14.5-fold the level of the MACS+ cell population. (G-H) 
Fluorescent immunohistochemical staining of GFAP (cyan) in formaldehyde-fixed paraffin-
embedded thin sections with green counterstain, scale bars 50 µm: (G) GFAP staining is not seen 
in the parenchyma of the pituitary anterior lobe. (H) In mouse brain positive controls, GFAP 
staining can be seen in astrocytes in the mouse brain. 
Figure 5:  No colocalisation of SOX2 and PDGFRβ in anterior pituitary
(A) Fluorescent immunohistochemical staining of PDGFRβ (blue) and SOX2 (green) in 
formaldehyde-fixed paraffin-embedded thin sections of wild-type mouse pituitaries. 
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